Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19

BACKGROUND: The use of statins, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs), and anticoagulants may be associated with fewer adverse outcomes in COVID-19 patients. METHODS: Nested within a cohort of 800,913 patients diagnosed with COVID-19 between April 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Leonard K., Kuo, Yong-Fang, Westra, Jordan, Raji, Mukaila A., Albayyaa, Mohanad, Allencherril, Joseph, Baillargeon, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2023
Materias:
Clinical Research Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032048/
https://www.ncbi.nlm.nih.gov/pubmed/37207280
http://dx.doi.org/10.1016/j.ajmo.2023.100040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032048/
https://www.ncbi.nlm.nih.gov/pubmed/37207280
http://dx.doi.org/10.1016/j.ajmo.2023.100040

Ejemplares similares